Beta-Blocker therapy for acute coronary syndrome and stable coronary artery disease: Current issues and outcomes

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Beta-blocker therapy is critical in the management of coronary artery disease. Although its role is better defined in the management of acute myocardial infarction with areas of lingering controversy, β-blocker use in terms of cardiovascular outcomes in stable coronary artery disease is less understood. In this heterogenous population, important questions arise about what groups of patients benefit most from β-blockers and the appropriate duration of use.

Original languageEnglish (US)
Title of host publicationBeta-Blockers
Subtitle of host publicationPhysiological, Pharmacological and Therapeutic Implications
PublisherNova Science Publishers, Inc.
Pages287-298
Number of pages12
ISBN (Electronic)9781536133127
ISBN (Print)9781536133110
StatePublished - Jan 1 2018

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Beta-Blocker therapy for acute coronary syndrome and stable coronary artery disease: Current issues and outcomes'. Together they form a unique fingerprint.

  • Cite this

    Kesarwani, M. (2018). Beta-Blocker therapy for acute coronary syndrome and stable coronary artery disease: Current issues and outcomes. In Beta-Blockers: Physiological, Pharmacological and Therapeutic Implications (pp. 287-298). Nova Science Publishers, Inc..